Medtronic Q3 FY25 10-Q Filed

Ticker: MDT · Form: 10-Q · Filed: 2025-02-25T00:00:00.000Z

Sentiment: neutral

Topics: 10-Q, financials, debt

TL;DR

Medtronic's Q3 FY25 10-Q is in, showing debt details and financial status. All good.

AI Summary

Medtronic plc filed its 10-Q for the period ending January 24, 2025, reporting on its financial performance for the third quarter of fiscal year 2025. The filing details various financial instruments and debt obligations, including senior notes due in 2025 and 2027, and mentions its fiscal year end as April 25, 2025. The company is based in Galway, Ireland, with its principal executive offices located at Building Two, Parkmore Business Park West.

Why It Matters

This filing provides investors with an update on Medtronic's financial health and debt structure as of early 2025, crucial for assessing its ongoing operational stability and investment potential.

Risk Assessment

Risk Level: low — This is a routine quarterly filing providing standard financial disclosures and does not indicate any immediate or significant risks.

Key Numbers

Q3 2025 — Fiscal Quarter (Reporting period for the 10-Q)
04/25 — Fiscal Year End (Medtronic's fiscal year concludes on this date)

Key Players & Entities

Medtronic plc (company) — Filer of the 10-Q
2025-01-24 (date) — End of reporting period
2025-02-25 (date) — Filing date
Galway, Ireland (location) — Company's business address
MD T (company) — Ticker symbol reference

FAQ

What is the primary purpose of this 10-Q filing?

This 10-Q filing provides Medtronic plc's quarterly financial statements and disclosures for the period ending January 24, 2025.

When was this 10-Q filed with the SEC?

This 10-Q was filed on February 25, 2025.

What is Medtronic's fiscal year end?

Medtronic's fiscal year ends on April 25th (0425).

Where is Medtronic plc's principal business address?

Medtronic plc's principal business address is Building Two, Parkmore Business Park West, Galway, L2 H91 4K49.

What specific debt instruments are mentioned in the filing data?

The filing data mentions various senior notes, including 'A0.250SeniorNotesDue2025Member', 'A0.000SeniorNotesDue2025Member', 'A2.625SeniorNotesDue2025Member', and 'A1.125SeniorNotesDue2027Member'.

From the Filing

0001613103-25-000022.txt : 20250225 0001613103-25-000022.hdr.sgml : 20250225 20250225161728 ACCESSION NUMBER: 0001613103-25-000022 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 119 CONFORMED PERIOD OF REPORT: 20250124 FILED AS OF DATE: 20250225 DATE AS OF CHANGE: 20250225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 0425 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 25663497 BUSINESS ADDRESS: STREET 1: BUILDING TWO PARKMORE BUSINESS PARK WEST CITY: GALWAY STATE: L2 ZIP: H91 4K49 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: BUILDING TWO PARKMORE BUSINESS PARK WEST CITY: GALWAY STATE: L2 ZIP: H91 4K49 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 10-Q 1 mdt-20250124.htm 10-Q mdt-20250124 0001613103 4/25 false Q3 2025 H91 4K49 P6Y P6Y P3Y P3Y P5Y P5Y P8Y P8Y P5Y P5Y P6Y P6Y P8Y P8Y P5Y P5Y P12Y P12Y P12Y P12Y P9Y P9Y P12Y P12Y P10Y P10Y P12Y P12Y P20Y P20Y P12Y P12Y P30Y P30Y P20Y P20Y P30Y P30Y P20Y P20Y P30Y P30Y P20Y P20Y P30Y P30Y P30Y P30Y P19Y P19Y P30Y P30Y P30Y P30Y P30Y P30Y P30Y P30Y P29Y P29Y xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure mdt:tranche iso4217:EUR iso4217:JPY mdt:plaintiff mdt:claim mdt:lawsuit mdt:segment 0001613103 2024-04-27 2025-01-24 0001613103 mdt:A0.250SeniorNotesDue2025Member 2024-04-27 2025-01-24 0001613103 mdt:A0.000SeniorNotesDue2025Member 2024-04-27 2025-01-24 0001613103 mdt:A2.625SeniorNotesDue2025Member 2024-04-27 2025-01-24 0001613103 mdt:A1.125SeniorNotesDue2027Member 2024-04-27 2025-01-24 0001613103 mdt:A0.375SeniorNotesDue2028Member 2024-04-27 2025-01-24 0001613103 mdt:A3.000SeniorNotesDue2028Member 2024-04-27 2025-01-24 0001613103 mdt:A3.650SeniorNotesDue2029Member 2024-04-27 2025-01-24 0001613103 mdt:A1.625SeniorNotesDue2031Member 2024-04-27 2025-01-24 0001613103 mdt:A1.000SeniorNotesDue2031Member 2024-04-27 2025-01-24 0001613103 mdt:A3.125SeniorNotesDue2031Member 2024-04-27 2025-01-24 0001613103 mdt:A0.750SeniorNotesDue2032Member 2024-04-27 2025-01-24 0001613103 mdt:A3.375SeniorNotesDue2034Member 2024-04-27 2025-01-24 0001613103 mdt:A3.875SeniorNotesDue2036Member 2024-04-27 2025-01-24 0001613103 mdt:A2.250SeniorNotesDue2039Member 2024-04-27 2025-01-24 0001613103 mdt:A1.500SeniorNotesDue2039Member 2024-04-27 2025-01-24 0001613103 mdt:A1.375SeniorNotesDue2040Member 2024-04-27 2025-01-24 0001613103 mdt:A4.150SeniorNotesDue2043Member 2024-04-27 2025-01-24 0001613103 mdt:A1.750SeniorNotesDue2049Member 2024-04-27 2025-01-24 0001613103 mdt:A1.625SeniorNotesDue2050Member 2024-04-27 2025-01-24 0001613103 mdt:A4.150SeniorNotesDue2053Member 2024-04-27 2025-01-24 0001613103 2025-02-19 0001613103 2024-10-26 2025-01-24 0001613103 2023-10-28 2024-01-26 0001613103 2023-04-29 2024-01-26 0001613103 2025-01-24 0001613103 2024-04-26 0001613103 us-gaap:CommonStockMember 2024-04-26 0001613103 us-gaap:AdditionalPaidInCapitalMember 2024-04-26 0001613103 us-gaap:RetainedEarningsMember 2024-04-26 0001613103 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-26 0001613103 us-gaap:ParentMember 2024-04-26 0001613103 us-gaap:NoncontrollingInterestMember 2024-04-26 0001613103 us-gaap:RetainedEarningsMember 2024-04-27 2024-07-26 0001613103 us-gaap:ParentMember 2024-04-27 2024-07-26 0001613103 us-gaap:NoncontrollingInterestMember 2024-04-27 2024-07-26 0001613103 2024-04-27 2024-07-26 0001613103 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-27 2024-07-26 0001613103 us-gaap:CommonStockMember 2024-04-27 2024-07-26 0001613103 us-gaap:AdditionalPaidInCapitalMember 2024-04-27 2024-07-26 00016131